| Dr Marvin Renell Kym, MD | |
|
2301 W A St, Moscow, ID 83843-4042 | |
| (208) 883-1135 | |
| (208) 892-0174 |
| Full Name | Dr Marvin Renell Kym |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 2301 W A St, Moscow, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316932601 | NPI | - | NPPES |
| 10298 | Other | ID | BCI |
| 003782400 | Medicaid | ID | |
| 000010003567 | Other | ID | REGENCE |
| 8138554 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | WA0029535 (Washington) | Secondary |
| 207X00000X | Orthopaedic Surgery | M6029 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gritman Medical Center | Moscow, ID | Hospital |
| St Marys Hospital And Clinics | Cottonwood, ID | Hospital |
| Syringa General Hospital | Grangeville, ID | Hospital |
| Clearwater Valley Hospital & Clinics | Orofino, ID | Hospital |
| St Joseph Regional Medical Center | Lewiston, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gritman Medical Center Inc | 4981984390 | 20 |
News Archive
The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.
A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida.
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body's natural defence systems.
Patients with a certain drug-resistant urinary tract infection were more likely to have a relapse of their infection within a week than those with non-resistant infections and were more likely to be prescribed an incorrect antibiotic according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 8 days ago
| Entity Name | Gritman Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619988144 PECOS PAC ID: 8729070164 Enrollment ID: O20040402001021 |
News Archive
The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.
A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida.
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body's natural defence systems.
Patients with a certain drug-resistant urinary tract infection were more likely to have a relapse of their infection within a week than those with non-resistant infections and were more likely to be prescribed an incorrect antibiotic according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 8 days ago
| Entity Name | Gritman Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477004828 PECOS PAC ID: 4981984390 Enrollment ID: O20161130002249 |
News Archive
The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.
A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida.
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body's natural defence systems.
Patients with a certain drug-resistant urinary tract infection were more likely to have a relapse of their infection within a week than those with non-resistant infections and were more likely to be prescribed an incorrect antibiotic according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 8 days ago
| Entity Name | St Joseph Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205368404 PECOS PAC ID: 8325325806 Enrollment ID: O20170606002496 |
News Archive
The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.
A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida.
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body's natural defence systems.
Patients with a certain drug-resistant urinary tract infection were more likely to have a relapse of their infection within a week than those with non-resistant infections and were more likely to be prescribed an incorrect antibiotic according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marvin Renell Kym, MD Po Box 8007, Moscow, ID 83843-0507 Ph: (208) 882-4511 | Dr Marvin Renell Kym, MD 2301 W A St, Moscow, ID 83843-4042 Ph: (208) 883-1135 |
News Archive
The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.
A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida.
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body's natural defence systems.
Patients with a certain drug-resistant urinary tract infection were more likely to have a relapse of their infection within a week than those with non-resistant infections and were more likely to be prescribed an incorrect antibiotic according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 8 days ago
Edwin M Tingstad, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 W A St, Suite 201, Moscow, ID 83843 Phone: 208-883-2828 | |
Steven E Pennington, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2500 W A St, Suite 201, Moscow, ID 83843 Phone: 208-883-2828 Fax: 208-882-2179 | |
Dr. Aaron James Vandenbos, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 W A St Ste 201, Moscow, ID 83843 Phone: 208-883-2828 Fax: 208-882-2179 | |
Charles A Jacobson, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2500 W A St, Suite 201, Moscow, ID 83843 Phone: 208-883-2828 Fax: 208-882-2179 | |
Mathew Zane Taylor, M.D, M.P.H. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 W A St Ste 201, Moscow, ID 83843 Phone: 208-883-2828 | |
Dr. Kyle J Hazelwood, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 W A St Ste 201, Moscow, ID 83843 Phone: 208-883-2828 Fax: 208-882-2179 |